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immunoreactive mass and mRNA levels have never been measured simultaneously in such individuals. Our hypothesis is that insulin resistance is associated with hypertriglyceridaemia and that this defect could be due to an impaired clearance of TG-rich particles by a decrease in adipose tissue LPL. The present study was initiated to address this issue, and we believe that it represents the first attempt to define the relationship between variations in insulin sensitivity, plasma PH-LPL activity and immunoreactive mass, adipose tissue LPL activity and immunoreactive mass, and adipose tissue LPL mRNA content.
Subjects and methods
Study population. Nineteen non-diabetic male volunteers were recruited for this study. They were in good general health, not taking any medication known to affect glucose or lipoprotein metabolism, and non-diabetic by conventional criteria [16] . Of these, only one volunteer had a blood pressure in the high range (161/90 mm Hg). The study was approved by Stanford University Human Subjects Committee, and each individual gave written consent upon admission to the General Clinical Research Center.
Metabolic evaluation. Each volunteer was studied on three different occasions, always after a 12 h overnight fast, at which time blood was obtained for measurement of fasting plasma insulin [17] , and TG [18] concentrations. Studies were performed in random order, over a period of 1 month and at least 3 days apart. On one morning, resistance to insulin-mediated glucose disposal was quantified by the insulin suppression test as described previously [19] . Briefly, steady-state plasma insulin and glucose (SSPG) concentrations were measured at 10 min intervals during the last 30 ). Since steady-state plasma insulin concentrations were similar in all individuals, the higher the SSPG concentration, the more insulin resistant the individual.
Measurement of plasma and tissue LPL activity
On a separate day, blood samples were obtained 30 min after an intravenous bolus injection of 100 units/kg of heparin [20] for determination of PH-LPL activity and its immunoreactive mass. Blood samples were kept on ice, plasma separated immediately, quick frozen in a dry-ice ethanol bath, and stored at -80°C until assayed in batches. Finally, approximately 0.5 g of subcutaneous adipose tissue was obtained under local anesthaesia by open biopsy from the lower abdominal wall on a third morning. This sample was rapidly frozen between two blocks of dry ice, and kept at -80°C until analysed, within 6 months, for tissue LPL activity, immunoreactive mass, and mRNA content. Since the heparin used for the PH-LPL could influence adipose tissue LPL activity, the biopsy was always performed at least 1 week apart.
PH-LPL activity was determined using a sonicated [ [22] , and radioactivity quantified by liquid scintillation spectrometry. In order to distinguish the activity of plasma PH-LPL activity from that of residual hepatic lipase, high salt concentration (1 mol/l NaCl in presence of human serum) was employed to inhibit LPL and hepatic lipase activities determined in a separate incubation [23] . These values were subtracted from the total lipolytic activity to obtain the PH-LPL values. The results are expressed as mmol of non-esterified fatty acid (NEFA) released per hour per ml of post-heparin plasma.
Total extractable adipose tissue LPL activity was measured after detergent extraction as described by Iverius and Brunzell [24] . Approximately 150 mg of frozen adipose tissue were homogenized with a polytron in 300 
Measurement of plasma and tissue LPL immunoreactive mass.
LPL immunoreactive mass was measured by a non-competitive indirect solid-phase ELISA, using two different polyclonal chicken anti-LPL antibodies, as described previously [25] . This immunoassay has been extensively validated by Kern's group [25] [26] [27] and the antibodies used were shown to identify both plasma and tissue LPL by Western blotting and immunoprecipitation. In brief, post-heparin plasma and adipose tissue extracts, prepared as described above, were diluted in a buffer containing 1 mol/l NaCl, 0.1 % Triton X-100, and protease inhibitors, and added to a microtitre plate coated with affinity purified anti-LPL antibodies (number 2271, 5 m l/ml in 0.1 mol/l carbonate buffer, pH 9.5). After incubation for 72 h at 4°C, the wells were washed and biotinylated second anti-LPL antibodies (number 2272, 0.3 m l/ml) were added. The colour was developed by addition of streptavidin-horseradish peroxidase and read at 490 nm using a spectrophotometer. LPL immunoreactive mass was expressed in relation to purified bovine LPL, and data expressed as pmol of immunoreactive LPL/g (for adipose tissue) or nmol/l (for plasma) assuming a molecular weight for LPL of 55 kDa. Under the aforementioned conditions, we have previously shown that hepatic lipase and Triton X-100 do not interfere with this ELISA and that serial dilutions of post-heparin plasma are paralleled to a curve for bovine LPL [26, 27] . Various parameters such as pH of antibodies buffers, incubation time and assay temperature have also been studied previously to obtain maximum sensitivity and accuracy [26] . By repeated measurements of the same frozen LPL sample, intra-and interassay variations were calculated at 5 and 16 %, respectively [25] . Finally, it is important to note that this LPL ELISA recognizes dimeric as well as monomeric forms of LPL [26, 27] . The antibodies were indeed shown to recognize inactive LPL under denaturing conditions [27] and to inhibit LPL activity [25, 26] .
Ribonuclease protection assay. The concentration of human LPL mRNA was determined using a sensitive ribonuclease protection assay [28] . For LPL, a 413 bp fragment (position 440-853) was subcloned into EcoRI-XbaI sites of the pBluescript KSII + from Stratagene La Jolla, Calif., USA). Similarly, an 87 bp PCR generated b -actin fragment (position 1304-1391; kindly provided by Dr. T. Wu, Stanford University Medical Center) was subcloned in EcoRV sites of pBS KSII + . The sequence and orientation of both clones were confirmed by the chain termination procedure as described by Sanger et al. [29] . The plasmids were linearized with appropriate restriction endonucleases and the antisense cRNA probes were synthesized using [ 32 P] rCTP and appropriate T7 or T3 RNA polymerase following the method supplied in the Strategene's in vitro transcription kit.
Total cellular RNA from adipose tissue samples was isolated using the acid guanidinium thiocyanate-phenol-chloroform extraction method [30, 31] ) and SDS (2 mg) and incubation for 15 min at 37°C. After phenol-chloroform extraction, the protected RNA-RNA hybrids were ethanol precipitated using yeast tRNA as a carrier. The pellet was dissolved in 15 m l of loading buffer (80 % formamide, 1 mmol/l EDTA, 0.1 % bromophenol blue and 0.1 % xylene cyanol, pH 8.0) and heated for 5 min at 85°C. The protected fragments were separated on a 6 % acrylamide urea denaturing gel [33] . After electrophoresis, gels were exposed to Kodak XAR-5 film at -70°C with intensifying screens. For strong signals, gels were usually exposed for 6-12 h and for weaker signals for up to 48 h. To increase detection sensitivity and resolution, LPL and b -actin mRNA were quantified by eluting the silver grains of film as previously described [34] . The LPL mRNA content was normalized per unit b -actin and expressed in arbitrary units over b -actin. Initially, a series of experiments were also performed in which hybridizations were done on a range of input RNA (50, 75, 100, 150 and 200 mg equivalent of frozen adipose tissue), using a constant amount of medium-high specific activity probes. The results of these control studies are shown in Figure 1A and 1B, and it can be seen from these figures that both the LPL and b -actin mRNAs were expressed abundantly. In addition, the intensity of the respective protected fragments increased with increases in input RNA indicating a molar excess of probes. Although transcription of b -actin can be influenced by insulin [35, 36] , this has been studied in vitro with insulin doses that were 40-1000 times the plasma insulin concentrations found in our most insulin resistant volunteer. Thus, we believe that b -actin represents an appropriate standard under the conditions of our experiments.
Statistical analyses. Data are expressed as mean ± SD, and the relationship between variables was determined by Pearson correlation coefficient [37] using the Statistical Analysis System (SAS). Where indicated, a multiple regression analysis was also performed. Results Table 1 displays the mean ± SD and range of the variables measured in the 19 males studied. Their ages ranged from 33 to 72 years, and body mass index from 20.8 to 33.9 kg/m 2 . They were generally not hypertensive, and had normal glucose tolerance. However, there was an approximate 5-10 fold range of variation in fasting plasma insulin, fasting plasma triglycerides and the degree of insulin resistance (as documented by SSPG values). The activity and mass of both plasma PH-LPL and adipose tissue LPL are also presented, together with the adipose tissue LPL mRNA levels. Although not obvious from these data, it should be recognized that LPL activity per unit mass (mmol of NEFA released per hour/pmol of immunoreactive LPL mass) is higher in post-heparin plasma than that seen in adipose tissue. This conclusion is based on the following: PH-LPL activity 7 PH-LPL mass is ∼ 5.7 m mol NEFA per h/pmol of LPL; whereas adipose tissue LPL activity 7 adipose tissue LPL mass is ∼ 0.6 m mol NEFA per h/pmol of LPL. Consequently, LPL specific activity in post-heparin plasma is approximately 10 times the specific activity of adipose tissue in the basal state. In the remainder of this section we will present some salient points of the relationships among these measurements.
As shown in Figure 2 , both plasma PH-LPL activity and mass were significantly correlated with fasting plasma TG concentration (r = -0.51, p < 0.03, and r = -0.53, p < 0.02, Fig. 2A and B, respectively) . On the other hand, there was no correlation between TG concentration and either adipose tissue LPL activity or mass (data not shown).
Plasma TG concentration correlated with SSPG concentration (r = 0.54, p < 0.02), and the results in Figure 3A and B demonstrate that plasma PH-LPL activity (r = -0.52) and immunoreactive mass (r = -0.49) were also significantly correlated to SSPG concentration (p < 0.03). Similar, but somewhat weaker correlations were seen between fasting plasma insulin concentration and plasma PH-LPL activity (r = -0.45, p < 0.06), and PH-LPL mass (r = -0.42, p < 0.07) (data not shown). These data indicate that the more insulin resistant an individual, the less the LPL activity and immunoreactive mass in post-heparin plasma. There was however no relationship between SSPG or fasting plasma insulin concentration and either adipose tissue LPL mass or activity (data not shown).
In contrast to adipose tissue LPL activity and mass, adipose tissue LPL mRNA content correlated highly with plasma TG concentration (r = -0.68, p < 0.001, Fig. 4A ). In addition, as can be seen in Figure 4B , adipose tissue mRNA content also correlated significantly with SSPG concentration (r = -0.68, Fig. 4C) . A multiple regression analysis was performed in order to see whether there was an independent relationship between insulin resistance (as assessed by SSPG) and adipose tissue LPL mRNA levels. With body mass index, triglycerides and age included in the model, the relationship between adipose tissue LPL mRNA and SSPG was still significant (standardized estimate = -0.65, p < 0.002). Fasting insulin was not included in the model since it is strongly correlated to SSPG. Alternatively, the study population was divided according to their SSPG concentrations, into an insulin resistant (n = 9, SSPG = 12.2 ± 1.0 mmol/l), and an insulin sensitive group (n = 10, SSPG = 5.0 ± 0.5 mmol/l). Steadystate LPL mRNA levels were statistically lower in the insulin resistant subgroup (1.46 ± 0.14 units over b -actin) as compared to the insulin-sensitive individuals (2.10 ± 0.06 units over b -actin; p < 0.001). Although there was a significant correlation between plasma PH-LPL activity and mass (Fig. 5A , r = 0.60, p < 0.01) and adipose tissue LPL activity and mass (Fig. 5B , r = 0.76, p < 0.001), there was no relationship between either plasma PH-LPL activity 
Discussion
The results presented demonstrate that the more resistant an individual is to insulin-mediated glucose disposal, the lower will be the plasma PH-LPL activity (r = -0.52, p < 0.03) and adipose tissue LPL mRNA levels (r = -0.68, p < 0.001). In addition, we have shown for the first time that a similar relationship exists between both plasma PH-LPL immunoreactive mass and the ability of insulin to stimulate glucose disposal (r = -0.49, p < 0.03). Thus, it seems reasonable to add a decrease in plasma PH-LPL activity and mass, and adipose tissue LPL mRNA levels to the cluster of abnormalities associated with the insulin resistance syndrome [6, 38] . The observation that plasma PH-LPL activity and mass were highly correlated (r = 0.60, p < 0.01), and that both were inversely correlated with fasting plasma TG concentration (r = -0.51, p < 0.03 and r = -0.52, p < 0.02, respectively), are reminiscent of the earlier findings by Babirak et al. [39] in patients with familial combined hyperlipidaemia. Of note in this context is the recent observation from our research group that individuals with the form of dyslipidaemia that characterizes familial combined hyperlipidaemia (a high TG and a high LDL-cholesterol) are also insulin resistant [40] . Based upon the relationships we observed between insulin resistance and LPL mRNA in adipose tissue, as well as that seen between plasma PH-LPL activity and mass and LPL mRNA content in adipose tissue, we would offer the following formulation. Insulin acts normally to regulate adipose tissue LPL activity; a notion consistent with previous observations that insulin can stimulate LPL secretion by isolated adipocytes [41, 42] , as well as the fact that adipose tissue LPL activity reaches its highest level in the fed state [43] or in response to an insulin infusion [44, 45] . However, as we have recently shown [46] , the ability of insulin to inhibit adipose tissue lipolysis is highly correlated with its ability to stimulate insulinmediated glucose disposal by muscle. Thus, it could be speculated that the ability of insulin to modulate LPL mRNA in adipose tissue is defective in insulin resistant subjects, thereby accounting for the fact that the higher the SSPG concentration, the measure of insulin resistance, the lower the adipose tissue LPL mRNA (r = -0.68, p < 0.001). Since adipose tissue LPL mRNA content also correlated with plasma PH-LPL mass (r = 0.57, p < 0.01), it seems reasonable to propose that the relationship between SSPG and plasma PH-LPL mass was secondary to the inability of insulin to stimulate LPL mRNA in adipocytes of insulin resistant individuals. These results are also consistent with the evidence that responsiveness of adipose tissue LPL activity was decreased in obese individuals in proportion to their degree of insulin resistance [14] .
In contrast to the relatively straightforward relationships outlined above, was the lack of correlation noted between measures of adipose tissue LPL activity and mass with plasma PH-LPL activity or mass. One should also remember that there was no correlation between adipose tissue LPL mRNA and plasma PH-LPL activity suggesting that adipose tissue might be releasing mainly inactive LPL as suggested by Coppack et al. [47] . Our data show that LPL specific activity was indeed 10 times lower in adipose tissue than in post-heparin plasma. At the simplest level, it is possible that adipose tissue LPL activity and mass have relatively little to do with the amount of LPL released into plasma in response to heparin. For example, it is likely that the majority of LPL protein leaves the adipose tissue as it interacts with chylomicrons and/or VLDL [48] . Under these conditions, the mass of LPL present in the adipose tissue at any given time represents the residual LPL pool, and its measurement may provide little, if any, insight as to the functional state of LPL activity. The discrepancy between adipose tissue and post-heparin LPL activity and mass may also be a function of differences in insulin's regulation of LPL in adipose tissue compared to muscle. Pollare et al. [12] have recently noted that adipose tissue LPL was not decreased in obese, hyperinsulinaemic (presumably insulin resistant) individuals, whereas muscle LPL activity was decreased. Our inability to detect a relationship between plasma PH-LPL activity (and mass) and adipose tissue LPL activity (and mass) may therefore simply be a reflection of the fact that muscle is the tissue most affected in insulin resistant individuals. It is also possible that the lack of correlation between adipose tissue LPL and insulin resistance can be explained by the fact that we measured adipose tissue LPL in a fasting state at a time when insulin levels are the lowest. Most reports on the relationship of insulin resistance and adipose tissue LPL have indeed looked at changes in tissue LPL in response to an exogenous insulin infusion [13, 14, 44, 45] . On the other hand, plasma PH-LPL activity (and mass) might represent a contribution from both adipose tissue and muscle. An earlier report by Taskinen et al. [49] showed in non-diabetic individuals, that PH-LPL was closely correlated to LPL activity in both adipose tissue and skeletal muscle. The fact that we only measured total extractable tissue LPL activity and mass might have obscured some important changes in the functional (or heparin-releasable) LPL anchored on the extracellular matrix of adipose tissue. Consequently, it is possible that although measurement of total adipose tissue LPL activity and mass may yield useful information, these values, per se, may provide little knowledge as to the LPL activity in the functional or the plasma compartment. Since the total LPL pool was utilized to measure LPL activity, it is indeed difficult to conclude that the functional LPL was altered in adipose tissue of insulin resistant individuals.
The lack of a relationship between adipose tissue LPL mRNA content and adipose tissue LPL activity and mass is more complicated. The fact that there was a significant correlation between adipose tissue LPL activity and mass suggests that the lack of a relationship was not a simple function of insensitive methodology. In the most general sense, these findings suggest that there could be important post-transcriptional and post-translational mechanisms involved in the regulation of adipose tissue LPL mass and activity in insulin resistance. In this context it is necessary to keep in mind that a decrease in steady-state LPL mRNA content can result from a decrease in rate of RNA transcription and/or a decrease in cytoplasmic RNA stability. Therefore, steady-state levels of LPL mRNA are not necessarily direct correlates of the number of LPL mRNA molecules transcribed from DNA and/or used by the translational apparatus. For example, if despite lower LPL mRNA levels, the same number of LPL mRNA molecules are translated, LPL mass and activity might not be affected. On the other hand, it is possible that a smaller number of LPL mRNA molecules were translated and that post-translational phenomena might have played an even more important role in maintaining the concentration of mature vs immature LPL proteins and LPL activities in adipose tissue. Post-translational regulatory mechanisms have indeed been well documented in humans as well as in animals [42, 43, [50] [51] [52] [53] . These mechanisms are complex intracellular processes that include intracellular LPL degradation by lysosomes [53] . More specifically, it has been documented that 80 % of newly synthesized LPL can be degraded in adipocytes incubated under basal conditions [53] [54] [55] . Obviously, all of these issues may have contributed to the lack of a correlation between adipose tissue LPL mRNA content and LPL activity and mass. On the other hand, although we are unsure as to why either adipose tissue LPL mass or activity did not correlate with adipose tissue mRNA content, it should be emphasized that adipose tissue mRNA content was highly correlated with degree of insulin resistance, both fasting insulin and TG concentrations, as well as with post-heparin plasma the number of LPL molecules in plasma. Thus, adipose tissue concentration of mRNA was clearly related to the whole body physiological variables we measured. While one insulin resistant subject had a mild hypertension (161/ 90 mm Hg), his data were not different from the other insulin resistant individuals studied in this protocol.
In conclusion, the results presented provide further support for the view that plasma TG concentrations in non-diabetic individuals are directly associated to degree of insulin resistance and inversely with plasma PH-LPL activity [6, 10, 11, [56] [57] [58] . In addition to providing further evidence that resistance to insulin-mediated glucose disposal in non-diabetic individuals is associated with a decrease in plasma PH-LPL activity, the current results show that the changes in plasma PH-LPL mass paralleled those in activity. Since adipose tissue mRNA content was also inversely correlated with degree of insulin resistance, it is proposed that the ability of insulin to stimulate the transcription of the LPL gene or to maintain the cytoplasmic LPL mRNA levels is impaired in the insulin resistant individuals, and contributes to the decrease in plasma PH-LPL activity and mass seen in this situation. Finally, irrespective of the mechanism involved, the results indicate that there are parallel defects in the ability of insulin to modulate glucose disposal and regulate LPL function.
